Scirica, Benjamin M <br/><br/>
Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.  [electronic resource] 

 -  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology  Jan 2015 
 - 32-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-2092 
<br/><br/><label>Standard No.: </label>10.1093/europace/euu217  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides--administration & dosage<br/>Acute Coronary Syndrome--drug therapy<br/>Age Distribution<br/>Aged<br/>Aged, 80 and over<br/>Atrial Fibrillation--drug therapy<br/>Comorbidity<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Massachusetts--epidemiology<br/>Piperazines--administration & dosage<br/>Placebo Effect<br/>Prevalence<br/>Ranolazine<br/>Risk Factors<br/>Sodium Channel Blockers--administration & dosage<br/>Survival Rate<br/>Treatment Outcome